RGNX 9.38 ▲ 0.21% Live Trading Data - Stocknear

REGENXBIO Inc.

NASDAQ: RGNX · Real-Time Price · USD
9.38
0.02 (0.21%)
At close: Sep 26, 2025, 10:58 AM
0.21%
Bid 9.31
Market Cap 473.57M
Revenue (ttm) 155.78M
Net Income (ttm) -175.57M
EPS (ttm) -3.38
PE Ratio (ttm) -2.77
Forward PE -4.55
Analyst Buy
Dividends n/a
Ask 9.38
Volume 48,085
Avg. Volume (20D) 596,176
Open 9.37
Previous Close 9.36
Day's Range 9.16 - 9.45
52-Week Range 5.04 - 12.22
Beta 1.17
Ex-Dividend Date n/a

About RGNX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RGNX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RGNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
REGENXBIO Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-17.06%
Regenxbio shares are trading lower after the compa... Unlock content with Pro Subscription
4 months ago
+2.63%
RGNX stock has given up its prior gain. Regenxbio shares were trading higher following Q1 financial results and after the company announced FDA acceptance and priority review of BLA for RGX-121.